Jeito logo.png
Jeito Capital co-leads EUR 80 million Series B financing in European oncology company, Precirix
16 mars 2022 03h00 HE | Jeito Capital
Jeito Capital co-leads EUR 80 million Series B financing in European oncology company, Precirix Jeito Capital chooses Precirix, a clinical-stage biotechnology company developing precision...